SciVision Biotech Inc.

SciVision Biotech Inc. is a leading pharmaceutical manufacturing company dedicated to creating innovative solutions for health and beauty. Founded in 2001 and listed on the Taiwan Stock Exchange (Stock symbol: 1786), SciVision Biotech Inc. specializes in Hyaluronic acid products, utilizing its own-developed Cross-linked Hyaluronic Acid Platform (CHAP) to precisely control the characteristics of its offerings. This technology has established SciVision Biotech Inc. as a leader in medical-grade Hyaluronic acid products. SciVision Biotech Inc. is located primarily at No. 1, South 1st Rd., Kaohsiung, 806, TW.

Addressing the growing demands of an aging society and the increasing pursuit of beauty and health, SciVision Biotech Inc. offers a comprehensive range of Hyaluronic acid products. These include dermal fillers for medical and cosmetic surgical use, anti-adhesion gels for surgical applications, and viscosupplements for the treatment of knee osteoarthritis. These high-level medical devices are poised to drive commercial growth for the next decade and beyond.

SciVision Biotech Inc. is committed to expanding its technological capabilities and contributing to the health and beauty sectors. With a new GMP-certified manufacturing facility in Kaohsiung Cianjhen Technology Industrial Park, built to FDA standards and equipped with advanced automation, SciVision Biotech Inc. is well-positioned to meet growing production needs and collaborate with pharmaceutical and specialty companies worldwide. SciVision Biotech Inc.'s vision is to leverage its accumulated technologies and experience to benefit humankind. We invite the manager of SciVision Biotech Inc. to create a customized and exclusive company showcase and product listing on our platform.